3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Leukemia
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Estrogen Receptor Positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
capivasertib
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Estrogen Receptor Positive Breast Cancer
×
capivasertib
×
Clear all
NCT01992952
2025-11-26
FAKTION
Velindre NHS Trust
Phase 1/2
Active not recruiting
149 enrolled